Evaluation of S-1 as third- or further-line chemotherapy in advanced non-small-cell lung cancer.
Ono A, Naito T, Murakami H, Takahashi T, Nakamura Y, Tsuya A, Kaira K, Igawa S, Shukuya T, Tamiya A, Kaira R, Endo M, Yamamoto N.
Ono A, et al. Among authors: tamiya a.
Int J Clin Oncol. 2010 Apr;15(2):161-5. doi: 10.1007/s10147-010-0034-0. Epub 2010 Mar 4.
Int J Clin Oncol. 2010.
PMID: 20198400